I-BET151

Artikelnummer	Größe	Manual	Lieferzeit	Preis
LKT-I0516.5	5 mg	-	3 - 8 Werktage*	236,00 €
LKT-I0516.10	10 mg	-	3 - 8 Werktage*	346,00 €
LKT-I0516.25	25 mg	-	3 - 8 Werktage*	662,00 €

Bei Fragen nutzen Sie gerne unser Kontaktformular.
Bestellen Sie auch per E-Mail: info@biomol.com
Größere Menge gewünscht? Bulk-Anfrage

I-BET-151 is a BET bromodomain (BRD) inhibitor that inhibits BRD2, BRD3, and BRD4. I-BET-151... mehr

Menü schließen

Produktinformationen "I-BET151"

I-BET-151 is a BET bromodomain (BRD) inhibitor that inhibits BRD2, BRD3, and BRD4. I-BET-151 exhibits anticancer chemotherapeutic and anti-inflammatory activities. In vitro and in vivo, this compound induces apoptosis and inhibits cellular proliferation in various cancer models. I-BET-151 inhibits recruitment of the P-TEFb component of cyclin-dependent kinase 9 (CDK9) to chromatin, causing transcriptional regression of Myc. I-BET-151 also inhibits bacteria-induced inflammation and sepsis in animal models.

Schlagworte:	GSK-1210151A, GSK1210151A
Hersteller:	LKT Laboratories
Hersteller-Nr:	I0516

Eigenschaften

Anwendung:	pan-BET family inhibitor
MW:	415.44 D
Reinheit:	>98%
Format:	Solid

Datenbank Information

CAS :	1300031-49-5\| Passende Produkte
KEGG ID :	K11722 \| Passende Produkte

Handhabung & Sicherheit

Lagerung:	+20°C
Versand:	+20°C (International: +20°C)
Signalwort:	Danger
GHS-Piktogramme:
H-Sätze:	H301, H413
P-Sätze:	P264, P270, P273, P321, P330, P301+P310, P405, P501